William J. Phd Link

William J. Phd Link is a declared insider at 5 companies (board member); the most frequent names are Tarsus Pharmaceuticals, Inc., RxSight, Inc. and Oyster Point Pharma, Inc. Over a trading history stretching from 12 May 2021 to 15 September 2026, the count stands at 43 filings.

No open-market purchase appears, only 8 sales worth €7.5M. Besides market trades, the filings include 11 share grants and 4 option exercises. 2026 to date brings no purchases and 4 sales.

Most recently, on 17 September 2026, the filings show an option exercise in Tarsus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.